CRA：2026年5月欧洲准入障碍门户第四年数据收集的结果-最终报告（英文版）

In April 2022, EFPIA and its members committed to a series of actions designed to reduce disparities in access across Europe. The European Access Hurdles Portal (the “Portal”) was launched then as an industry-led initiative to increase transparency regarding the root causes of unavailability of innovative medicines in Europe—a key issue affecting patient access to innovative medicines. It is intended to identify and report on the multifactorial root causes of delays in pricing and reimburseme